Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice

Q Long, H Deng, J Chen, J Hu, B Liu, P Liao, Y Lin… - MedRxiv, 2020 - medrxiv.org
… the feature of acute antibody response to SARS-CoV-2. A cohort of 52 COVID-19
suspects and 64 close contacts were enrolled to evaluate the potentiality of the antibody test. …

[HTML][HTML] In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

M Diamond, R Chen, E Winkler, J Case, I Aziati… - Research …, 2021 - ncbi.nlm.nih.gov
… -2 strains to the indicated individual or combinations of mAbs. … of SARS-CoV-2 spike variation
on antibody neutralization in … To evaluate the efficacy of the mAb combinations in vivo, we …

SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

J Fröberg, J Gillard, R Philipsen, K Lanke, J Rust… - Nature …, 2021 - nature.com
… persistence of mucosal antibodies following mild SARS-CoV-2 … persistence of mucosal
antibodies against SARS-CoV-2 antigens … For all antibody–antigen combinations, positive and …

Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein

D Van Egeren, A Novokhodko, M Stoddard, U Tran… - medRxiv, 2020 - medrxiv.org
… Similarly, we found that resistance to antibody combinations requiring two or fewer mutations
for resistance would establish quickly after widespread presence of nAbs (Fig. 5E-F). With …

IgA dominates the early neutralizing antibody response to SARS-CoV-2

D Sterlin, A Mathian, M Miyara, A Mohr… - Science translational …, 2021 - science.org
… to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of
SARS-CoV-2–specific neutralizing antibodies … Early SARS-CoV-2–specific humoral responses …

Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment.

D Focosi, S McConnell, DJ Sullivan… - Drug Resistance Updates, 2023 - Elsevier
… authorized anti-Spike monoclonal antibodies (mAbs). … so far, under different combinations
and in different patient subgroups. … a subsequent increase in SARS-CoV-2 sequences across …

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

EM Parzych, J Du, AR Ali, K Schultheis, D Frase… - Nature …, 2022 - nature.com
… Monoclonal antibody therapy has played an important role against SARS-CoV-2. Strategies
… in multiple animal challenge models of SARS-CoV-2 prophylaxis compared to protein …

Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant

P Mlcochova, D Collier, A Ritchie, SM Assennato… - Cell Reports …, 2020 - cell.com
antibodies perform against this variant. We assess the diagnostic accuracy of combined rapid
antibody … wild-type or the D614G spike mutant SARS-CoV-2. The overall detection rate for …

Anti-SARS-CoV-2 vaccines and monoclonal antibodies facing viral variants

A Chaqroun, C Hartard, E Schvoerer - Viruses, 2021 - mdpi.com
… This study also tested a combination of Regimens antibodies (REGN 10933 + REGN
10987), CoV2-2196 + CoV2-2130, and the combination LY-CoV 555 + CB6. The first two …

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

L Wieske, KPJ van Dam, M Steenhuis… - The Lancet …, 2022 - thelancet.com
… , combination of monotherapy and combination therapies in … total antibody bridging ELISA
to detect antibodies against the … to identify participants with previous SARS-CoV-2 infection. …